You are here

The programme is an ESO recommended activity and is held with the support of

About the SIOG Advanced Course

The SIOG Advanced Course in Geriatric Oncology is our unique CME accredited training programme lead by international experts in the field of geriatrics AND oncology designed to provide specific skills in assessment, care pathways and therapeutic choices about the elderly patients with cancer in order to provide the basis of the assessment and the multi-dimensional approach that should be applied to elderly cancer patients.

This 2-phase advanced course is addressed to professionals in the management of elderly cancer patients who will acquire knowledge on the general principles of cancer treatment as a multidisciplinarity with case based programmes, discussions and debates in geriatrics for clinical oncologists as well as in clinical oncology for geriatricians.

 

Course dates

Phase 1 - 3 1/2-day course in Treviso, Italy from June 28-July 1, 2017
Phase 2 - this phase consists in attending the SIOG 3-day Annual Conference, to be held in 2017 in Warsaw (Poland) from November 09-11, and it will end with a follow-up and wrap-up session with faculty

University Certificate will be provided to students only at the end of phase II on the proviso of attendance to both phases. 

Academic year: 2017

 

Location of the course

Phase 1 - Università Cattolica del Sacro Cuore - Centro Studi Achille e Linda Lorenzon - Viale Guglielmo Oberdan 5, 31100 Treviso, Italy
Phase 2 – Hilton Warsaw Hotel & Convention Centre, Grzybowska 63, Warsaw, 00-844, Poland. www.hilton.com/warsaw

 

Purpose of the course

The course aims are:

  1. To provide basic information related to cancer medicine to the geriatricians and to the application of geriatric principles to the clinical oncologists
  2. To train young medical oncologists and geriatricians to work together. These individuals will become the bridge between the oncological and geriatric teams in their own institutions

The course is addressed at:

  • Medical oncologists completing their training since less than 5 years and medical oncology fellows
  • Other clinical oncologists: surgical oncologists and radiotherapists completing their training since less than 5 years and radiotherapy fellows
  • Geriatricians completing their training since less than 5 years and geriatric fellows

 To register your interest and for further information please do not hesitate to contact: SIOG Head Office at events@siog.org

 

Endorsements

                                                                                

 

Under the auspices of

ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.

Pending endorsement

         

                                              

 

This is why people want to attend the SIOG Advanced Course in Geriatric Oncology

The programme is an ESO recommended activity and is held with the support of

Download


Scientific programme committee

Course director
Silvio Monfardini (IT)

Co-director
Etienne Brain (FR)

Course coordinator
Giuseppe Colloca (IT)

Members
Martine Extermann (US)
Pierre Soubeyran (FR)
Tanya Wildes (US)
Laurence Verhagen (CH) – ex-officio

Honorary members
Riccardo Audisio (GB)
Lodovico Balducci (US)

 

Course programme

The course consists in a common part addressed to both clinical oncologists and geriatricians and two other successive parts for clinical oncologists on one side and on the other side for geriatricians. Case presentation and discussion are in common.
The course faculty will take care of the case selection and their presentations, subdivision of the participants in 4 small groups, and to follow their internal analysis of the case, before presentation of the conclusions in the general discussion.
The faculty are continuously present during the course and remain available as individual mentors, if requested, during the course and thereafter to determine whether there has been development of multidisciplinary treatment teams in each participant's institution within one year and vitality of these teams at five years.


Endorsements / auspices

                                                                     

 

Under the auspices of

* ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.

 

Pending endorsement

The programme is an ESO recommended activity and is held with the support of

Course faculty list

Matti Aapro (CH)Andrea Luciani (IT)
Lodovicco Balducci (US)Silvio Monfardini (IT)
Etienne Brain (FR)Anita O'Donovan (IE)
Antonella Brunello (IT)Siri Rostoft (NO)
Kwok-Leung Cheung (UK)Pierre Soubeyran (FR)
Giuseppe Colloca (IT)Giampaolo Ugolini (IT)
Martine Extermann (US)Tanya Wildes (US)
Marije E Hamaker (NL)

 

Course faculty brief profiles and pictures

Matti Aapro

Clinique de Genolier, Genolier (CH)

Matti Aapro is presently Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland. He coordinates the SPCC programme of the European School of Oncology (ESO) and serves the International Society for Geriatric Oncology (SIOG) as Executive Board member.  He has been member of the Board of EORTC and ESMO. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC), is now on its Board of Directors for 2014-2016, and is appointed Co-Chair of MASCC’s Antiemetic Study Group, effective June 2014.
He is Editor-in-Chief of Critical Reviews in Oncology/Hematology, associate editor for the geriatric section of the Oncologist and founding editor of the Journal of Geriatric Oncology (JGO). He is past Associate Editor for Annals of Oncology. He directs the qualityoflife.elsevierresource.com website. He has authored more than 250 publications and his major interests are new drug development, breast cancer, supportive care, and cancer in the elderly. Dr Aapro is Doctor Honoris Causa of the University of Tampere  (2013) and has received the 2010 Acta Oncologica Award and the 2012 ASCO B.J. Kennedy prize.

 

Lodovico Balducci

H. Lee Moffitt Cancer Center and University of South Florida, Tampa (US)

Lodovico Balducci graduated from the Universita Cattolica del Sacro Cuore, Rome, Italy in 1968. Following a fellowship at the A. Gemelli General Hospital, Rome he moved to the US to complete a residency at the University of Mississippi Medical Center. Dr Balducci is currently Director of the Division of Geriatric Oncology at the Moffitt Cancer Center and Professor of Oncologic Sciences and Medicine and the University of South Florida in Tampa, Florida where he specialises in Hematology/Oncology and Medical Oncology. Dr Balducci’s research focuses on cancer and aging, which he has extended to three other areas: determination of life-expectancy and active life expectancy, polypharmacy in older cancer patients, and support of the caregiver. In addition, Dr Balducci has been involved in cooperative trials involving management of breast, lung, colorectal and prostate cancer.

 

Etienne Brain

Institut Curie - Hôpital René Huguenin, St. Cloud (FR)

Etienne GC Brain, MD PhD, has been working since 1998 as a medical oncologist at the Hôpital René Huguenin (Saint-Cloud, France), which is now part of the academic centre Institut Curie. He obtained both his MD and PhD from University Paris V René Descartes after leading works in preclinical and clinical pharmacology on alkylating agents in Boston (Dana Farber Cancer Institute and Boston University). He was the Deputy Director for Research at Centre René Huguenin from 2008-2009, until the merge with Institut Curie happened in 2010, making this "multi-sites” institution one of the largest one dedicated to breast cancer management in Europe.
Etienne GC Brain is the secretary of the Breast Cancer Group of EORTC and chairs the GERICO group (clinical research in geriatric oncology) at UNICANCER. He is very committed to clinical research, involved in many trials covering breast cancer and geriatric oncology. His most recent interest focuses on competing risks for mortality in older breast cancer patients, trying to better define the indication of systemic treatment in adjuvant setting, and is embodied in the national program ASTER 70s granted in 2011 by the French health ministry. He is (co)author of several publications in peer-reviewed journals, including the JAMA, Lancet Oncol and J Clin Oncol.
He is member of the Editorial Board of the J Geriatric Oncol. He is an active member of ASCO and ESMO. He is the current president of SIOG.

 

Antonella Brunello

Istituto Oncologico Veneto, Padova (IT)

I am full time consultant at the Division of Medical Oncology 1 at the Istituto Oncologico Veneto in Padova.
I specialized in Medical Oncology in 2008 and I am currently attending the Ph.D Programme in Oncology and Oncological Surgery at the University of Padova. I was an International Visiting Scholar at the Moffit Cancer Center – Senior Adult Oncology Program in the years 2006-2007.
Over my career, I have been committed to medical treatment and clinical research of solid tumors, with particular interest in cancer in the elderly, breast cancer and sarcoma.
I am currently involved as either principal investigator or co-investigator in clinical and translational research projects in oncogeriatric trials.
I authored more than 30 papers in peer-reviewed journals, most of them about breast cancer, sarcoma and cancer in the elderly.
I am serving as scientific secretary of the Hematological Toxicity Guidelines board of the Italian Association of Medical Oncology (AIOM) since 2012.
I am a current member of national and international scientific societies, among which AIOM, ESMO, ASCO, SIOG and I am a board member of the Veneto Regional Section of AIOM, and of the Italian Group for Geriatric Oncology (GioGer).

 

Kwok-Leung Cheung

School of Medicine, University of Nottingham Consultant Breast Surgeon, Royal Derby Hospital, (UK)

Mr Cheung qualified and trained at Queen Mary Hospital, Hong Kong. Upon completion of general surgery training, he conducted clinical and laboratory research at the University of Nottingham, UK, with a Doctor of Medicine (in the area of blood tumour markers) awarded in 2001.  He was then appointed as Consultant Breast Surgeon at Nottingham University Hospitals where he served as Head of Service, Breast Services (2007 - 2010) and Lead Clinician for Breast Cancer (2007 - 2011).  Mr Cheung joined the University of Nottingham as Clinical Associate Professor in 2004. He is also currently Consultant Breast Surgeon at Royal Derby Hospital.
He has obtained surgical fellowship status from Hong Kong, Edinburgh and America. Mr Cheung was selected as one of the 12 International Guest Scholars 2007 of the American College of Surgeons, as a recognition of his strong interests and commitment in teaching and research.
Mr Cheung is a member of the Faculty of Examiners for Intercollegiate MRCS and the Panel of Examiners of the Intercollegiate Specialty Board in General Surgery. Mr Cheung is also part of the National Cancer Peer Review team and an External Professional Advisor to the Parliamentary Health Service Ombudsman. He is a member of the American Society of Clinical Oncology, European Society of Breast Cancer Specialists, British Association of Cancer Surgery, Association of Breast Surgery, British Breast Group and International Society of Geriatric Oncology (SIOG). In 2015, he received the National Representative of the Year award from SIOG recognising his commitments to geriatric oncology and SIOG. Within SIOG, he currently serves as the UK National Representative, Chair of the Membership and National Representatives Committee, a member of the Surgical Task Force, the Executive Committee and the Board.
His research interests include breast cancer, surgery and non-operative therapies, endocrine and targeted therapies, and clinical trials. He leads a research programme on primary breast cancer in older women at the University of Nottingham, covering biology and clinical outcome, geriatric assessment and psychosocial aspects, and cost effectiveness of different therapeutic strategies. In 2010, Mr Cheung pioneered the Symposium on Primary Breast Cancer in Older Women in the UK, which has now become a biennial event, hosted by the University under the auspices of SIOG. Mr Cheung has published over 100 journal articles, in addition to a number of book chapters and meeting abstracts.

 

Giuseppe Colloca

Policlinico A. Gemelli, Università Cattolica Sacro Cuore, Roma, (IT)

Giuseppe Colloca is a medical doctor at Policlinico A. Gemelli in Rome, Italy. Graduated in Medicine and Surgery at Catholic University of Sacred Heart of Rome in 2001, after a fellowship in Geriatric Medicine (2006) in the same University, he spent one year in Senior Adult Oncology Group at Moffitt Cancer Center, Florida US and then, in the Palliative Care Unit at  Fundacio’ Hospital Asil de Granollers, Barcellon Spain. In 2014 he completed his PhD in Geriatric-Oncology.  Member of InterRAI group about geriatric assessment tools, his research and clinical interest are on cancer assessment and pain management in the elderly.

 

 

Martine Extermann

H. Lee Moffitt Cancer Center, Tampa, (US)

Dr. Martine Extermann is Professor of Oncology and Medicine at the University of South Florida. She is the Interim Program Leader of the Senior Adult Oncology Program at the Moffitt Cancer Center. She earned her medical diploma and her medical PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specialty Oncology-Hematology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her research focuses on cancer in the elderly. Her main areas of investigation are comorbidity, comprehensive assessment, and prediction/prevention of treatment toxicity in older cancer patients.

She served as President of the International Society of Geriatric Oncology (SIOG), of which she is also a founding board member. She served or is serving on several ASCO Committees, and on the Editorial Board of the Journal of Clinical Oncology. Dr. Extermann was presented at ASCO 2009 with the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology. She also received the SIOG Paul Calabresi Award in 2014, and a Lifetime Achievement Award in Geriatric Oncology from the German Society of Geriatrics and German Society of Hematology/Oncology in 2015.

 

Marije E Hamaker

Department of Internal Medicine, Diakonessenhuis, Utrecht, (NL)

Marije Hamaker has been working as a clinical geriatrician working at the Diakonessenhuis in Utrecht, the Netherlands since 2010. In 2012, she defended her PhD thesis on “Decision making in geriatric oncology”. She has remained active in geriatric oncology research, focussing on treatment decisions and patient-centred outcome measures in various cancer types, and additionally has set up a project regarding geriatric nephrology in 2014. She is an active member of the Dutch Geriatric Oncology Foundation, the Elderly Task Force of the EORTC as well as a member of SIOG and the Dutch Geriatrics Society.

 

 

Andrea Luciani

The Ospedale S Paolo, Milan (IT)

Andrea Luciani, graduated in Medicine and Surgey at University of Milan. After the fellowship in medical oncology he spent some months in Senior Adult Oncology Group at Moffit Cancer Center, Florida US. When he returned to Italy he took the postdoctoral degree in Pharmacology and Metabolic disease. He is now an assistant physician in medical oncology department at S. Paolo University Hospital in Milan. He is the chairman of EORTC Cancer In the Elderly Task Force and the National Representative for Italy at International Society of Geriatric Oncology (SIOG). He has been the scientific secretary of the AIOM guidelines on elderly cancer patients from 2012 until present. His main interests are cancer in the elderly, with a special focus on lung and genitourinary cancer.

 

Silvio Monfardini

Instituto Palazzolo,Fondazione  Don Gnocchi, Milan (IT)

Present position: Director Geriatric Oncology Program Istituto Palazzolo, Fondazione Don Gnocchi, Milano, Italy.
Past positions:
Chief of the Division of Medical Oncology of the Istituto Oncologico Veneto of Padua
Scientific Director of the Istituto Nazionale per lo Studio e la Cura dei Tumori of  Naples
Scientific Director of the Centro di Riferimento Oncologico of Aviano
Dr. Silvio Monfardini is the author the main fields of Medical Oncology of 340 indexed publications, of whom 95 dedicated to Geriatric Oncology
Member of the American Society of Clinical Oncology since 1972
Past President of the European Society for Medical Oncology (ESMO)
Past President of the (Associazione Italiana di Oncologia Medica (AIOM)
Past President of the “International Society of Geriatric Oncology” (SIOG)
Recipient in the year 2006 of the International Society of Geriatric Oncology “Paul Calabresi” Memorial lecture award and in 2015 of the B.J. Kennedy award for Geriatric Oncology 

 

Anita O'Donovan

Trinity College Dublin (IE)

Anita O'Donovan graduated with a BSc in Radiation Therapy from Trinity College Dublin (TCD) in 2002. She joined the Discipline of Radiation Therapy at TCD in 2011, as Assistant Professor, having previously worked in both clinical and research positions as a radiation therapist in Saint Luke’s Hospital, Dublin and Cork University Hospital. Her main research interest is geriatric oncology, more specifically geriatric assessment, education of oncology professionals, and the application of these measures in clinical practice.  As a starting point, Anita has conducted an international Delphi consensus study on geriatric assessment (GA) in Oncology, in close collaboration with Dr Supriya Mohile, geriatric oncologist, at the University of Rochester, who has undertaken a similar study from a US perspective.  The main focus of Anita’s research is the application of GA in radiotherapy clinical practice and outcomes of older cancer survivors in Ireland.
Anita is part of the TCD Ageing Theme Steering Committee, led by Professor Rose Anne Kenny, representing the theme “Cancer and Ageing”.  One of the main aims of this research centre is to optimise opportunities for collaborative research between different disciplines. Ageing research is a main focus of TCD’s strategic plan, and is one of the major themes prioritised by the college.
Anita has a keen interest in older patient advocacy and incorporating “service learning” principles into her teaching, promoting intergenerational solidarity and the adoption of positive attitudes towards older people by future healthcare professionals.  She is also involved in educational outreach for older people through liaison with Age Action Ireland.

 

Siri Rostoft

University of Oslo, Norway and City of Hope (NO)

Siri Rostoft is a medical doctor at Oslo University Hospital, Norway, specialized in internal medicine and geriatric medicine. She completed her PhD about geriatric assessment in older surgical cancer patients in 2011. Her main research interests in geriatric oncology are the clinical importance of geriatric assessment and interventions and frailty. She is a deputy editor for Journal of Geriatric Oncology.

 

 

 

Pierre Soubeyran

Institut Bergonie, Bordeaux (FR)

Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux, and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level (President of the Scientific Council of the French Society of Geriatric Oncology (SoFOG) and Coordinator of the French Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of the U1218 INSERM Cancer research unit and Director of the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie).
He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment.

 

Giampaolo Ugolini

University of Bologna (IT)

Dr. Giampaolo Ugolini is Associate Professor of Surgery at University of Bologna. He was a research fellow at Massachusetts General Hospital (Harvard University), clinical and research fellow at Rhode Island Hospital (Brown Medical School). His main clinical interest is surgery of the alimentary tract for cancer and inflammatory bowel disease. He is collaborating to several research activities on colorectal cancer and on geriatric oncology with SIOG surgical taskforce.

 

 

Tanya Wildes

Washington University School of Medicine, St. Louis, MO (US)

Tanya M. Wildes, MD, MSCI is a geriatric oncologist and Assistant Professor of Medicine at Washington University School of Medicine. She completed fellowships in hematology, oncology and geriatrics at Washington University.  Her research and clinical interests focus on older adults with multiple myeloma.  She also studies prevention of falls in older adults with cancer.   She is a member of the Cancer and Aging Research Group, serves as an institutional representative on the National Comprehensive Cancer Network Older Adult Oncology Guidelines panel and is also an active member of SIOG, currently serving as Chair of the Science and Education Committee.

The programme is an ESO recommended activity and is held with the support of

CME accreditation and diploma

The SIOG 2017 Advanced Course in Geriatric Oncology was granted 18 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

European Accreditation
European Accreditation is granted by the EACCME in order to allow participants who attend the above-mentioned activity to validate their credits in their own country.

Accreditation Statement
Accreditation by the EACCME confers the right to place the following statement in all communication materials including the registration website, the event programme and the certificate of attendance. The following statements must be used without revision:
"The 'International Society of Geriatric Oncoclogy (SIOG)' (or) 'SIOG Advanced Course on Geriatric Oncology' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net."

"The 'SIOG Advanced Course on Geriatric Oncology' is designated for a maximum of (or 'for up to') 18 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity."

"Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme."

"Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada."

EACCME credits
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

At the end of the course, in accordance with art. 6 of Law no. 341/1990, students will receive a certificate as provided by art. 2, paragraph 5, of Title I of the academic regulations of the University. In accordance with the programme of Continuing Medical Education, the students in a university course are exempted from acquiring the CME credits for the current year (or 50 CME credits).The Catholic University of the Sacred Heart reserves the right to not activate or cancel the course if it does not reach the coverage of expenses.

To obtain the final certification, students are required to attend at least 80% of the teaching and training and the successful completion of all course tests.

The programme is an ESO recommended activity and is held with the support of

Admission

Ideal profile of the advanced course candidate:

  • Medical oncologists and other clinical oncologists completing their training since less than 5 years and medical oncology fellows
  • Medical oncology fellows
  • Geriatricians completing their training since less than 5 years
  • Geriatric fellows
  • Fluency in English

 

Participation

Attendance is limited to a maximum of 35 participants and admittance is by competitive application. All applications will be reviewed by the Course committee who will make the selection of the course participants based on their application. Successful applicants must pay the admission fee in order to be granted admission to the course:

SIOG MemberEUR 1,350.00 (including registration to the SIOG Annual Conference for phase 2)
Non-SIOG MemberEUR 1,590.00 (including registration to the SIOG Annual Conference for phase 2)

Fees include:

  • Teaching and course documents,
  • Lunches and coffee breaks during the course in Treviso,
  • Welcome lunch and farewell dinner,
  • Access to online course proceedings,
  • 1 year SIOG membership for 2017 for those who are not a SIOG member
  • Registration to SIOG 2017 Annual Conference in Warsaw, Poland (November 9-11, 2017)

Not included in the fees are the travel expenses to the course in Treviso and to the Annual Conference in Warsaw, hotel accommodation, dinners in Treviso, any lunches and dinners during the Annual Conference and transfers.

 The admission process has now been closed. Applications are being reviewed and notifications to applicants will be sent in the beginning of March 2017.

 

Next steps

  • All applications will be reviewed by the Course committee once the admission process is closed (February 13, 2017)
  • All applicants will be informed about the outcome of the selection process in the beginning of March 2017
  • Successful applicants will have to pay their admission fee as marked above either by bank transfer or via PayPal
  • Once the payment has been received, applicants will receive their course confirmation along with all relevant course documents in due course

For further information please do not hesitate to contact: SIOG Head Office at events@siog.org

 

The programme is an ESO recommended activity and is held with the support of

Sponsors

The International Society of Geriatric Oncology thanks all sponsors for their support:

                             

 

Download

PDF iconSIOG 2017 Advanced Course - Industry partnership brochure.pdf

 

Opportunities for industry partners for the SIOG 2017 Advanced Course edition

Oncologists and Geriatricians need to work together!

Support this unique training programme and help us achieve this goal. Here is how:
Download our leaflet and contact Sabrina Marchal at sabrina.marchal@siog.org to discuss your participation.

Italian pharmaceutical companies

SIOG has chosen MCI Rome to collect - on behalf of SIOG - all applications from Italian pharmaceutical companies and file them with the appropriate Italian Health Ministry officials.

For further information and questions, please contact:
MCI Rome
Attn. Mrs Maria Grazia Paolelli
Via della Ferratella in Laterano 41
00184 Rome
Italy
T +39 06 70 49 5693
F +39 06 70 96 292
mariagrazia.paolelli-mci@mci-group.com